L Zahradová

Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse

Luděk Pour, Henrieta Grešlíková, Renata Kupská et al. · Haematologica · 2013 · 183 citations · Full text

Medicine, Hematology, Oncology +14

Efficacy and safety of Id-protein-loaded dendritic cell vaccine in patients with multiple myeloma – Phase II study results

L Zahradová, Klára Mollová, Darina Očadlíková et al. · Neoplasma · 2012 · 33 citations · Full text

Medicine, Immunology, Oncology +17

Phenotype of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance

Iva Burešová, Tomáš Büchler, Renata Suská et al. · Neoplasma · 2009 · 22 citations

Medicine, Hematology, Pathology +17

Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation

Henrieta Grešlíková, Romana Zaoralová, Hana Filková et al. · Neoplasma · 2010 · 19 citations · Full text

Life Sciences, Genetics, Hematology +17

[Partial regression of CNS lesions of Erdheim-Chester disease after treatment with 2-chlorodeoxadenosine and their full remission following treatment with lenalidomide].

Zdeněk Adam, A Sprláková, Zdeněk Řehák et al. · PubMed · 2011 · 17 citations

Medicine, Neurology, Pathology +15